The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 22, 2008
Filed:
Dec. 01, 2004
William A. Metz, Jr., Bridgewater, NJ (US);
Frank Halley, Chaville, FR;
Gilles Dutruc-rosset, Paris, FR;
Yong MI Choi-sledeski, Belle Mead, NJ (US);
Gregory Bernard Poli, Bethlehem, PA (US);
David Marc Fink, Lebanon, NJ (US);
Gilles Doerflinger, Les Ulis, FR;
Bao-guo Huang, Bridgewater, NJ (US);
Ann Marie Gelormini, Hillsborough, NJ (US);
Juan Antonio Gamboa, New York, NY (US);
Andrew Giovanni, Flemington, NJ (US);
Joachim E. Roehr, Bernardsville, NJ (US);
Joseph T. Tsay, Bridgewater, NJ (US);
Fernando Camacho, Union, NJ (US);
William Joseph Hurst, Oxford, NJ (US);
Stephen Wayne Harnish, Wharton, NJ (US);
Yulin Chiang, Convent Station, NJ (US);
William A. Metz, Jr., Bridgewater, NJ (US);
Frank Halley, Chaville, FR;
Gilles Dutruc-Rosset, Paris, FR;
Yong Mi Choi-Sledeski, Belle Mead, NJ (US);
Gregory Bernard Poli, Bethlehem, PA (US);
David Marc Fink, Lebanon, NJ (US);
Gilles Doerflinger, Les Ulis, FR;
Bao-Guo Huang, Bridgewater, NJ (US);
Ann Marie Gelormini, Hillsborough, NJ (US);
Juan Antonio Gamboa, New York, NY (US);
Andrew Giovanni, Flemington, NJ (US);
Joachim E. Roehr, Bernardsville, NJ (US);
Joseph T. Tsay, Bridgewater, NJ (US);
Fernando Camacho, Union, NJ (US);
William Joseph Hurst, Oxford, NJ (US);
Stephen Wayne Harnish, Wharton, NJ (US);
Yulin Chiang, Convent Station, NJ (US);
Aventis Pharmaceuticals Inc., Bridgewater, NJ (US);
Abstract
The present invention discloses and claims compounds of formula (I) as inhibitors of human casein kinase IF, and methods of using said compounds of formula (I) for treating central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) and methods for the preparation of compounds of formula (I) are also disclosed and claimed.